Growth Metrics

Omnicell (OMCL) Liabilities and Shareholders Equity (2016 - 2025)

Omnicell (OMCL) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 6.89% to $2.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.2 billion through Dec 2025, down 8.66% year-over-year, with the annual reading at $2.0 billion for FY2025, 6.89% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $2.0 billion at Omnicell, up from $1.9 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $2.3 billion in Q3 2024, with the low at $1.9 billion in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $2.1 billion, with a median of $2.1 billion recorded in 2025.
  • The sharpest move saw Liabilities and Shareholders Equity soared 60.42% in 2021, then fell 15.41% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $2.1 billion in 2021, then increased by 3.19% to $2.2 billion in 2022, then increased by 0.73% to $2.2 billion in 2023, then dropped by 4.76% to $2.1 billion in 2024, then decreased by 6.89% to $2.0 billion in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $2.0 billion, $1.9 billion, and $2.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.